In contrast, in mouse tumor models and patients with cancer, the capability of cDCs to process tumor antigens and activate T cells effectively will be weakened by the accumulation of lipids, which is caused by FAS activation and lipid uptake through the increased expression of Msr1 [137]. This evidence concerns the gene FAS and neoplasm.